CoChat

Comorbidity and medication in REM sleep behavior disorder: A multicenter case-control study

Open access
Frauscher, Birgit, Jennum, Poul, Ju, Yo-El S., Postuma, Ronald B., Arnulf, Isabelle, Cochen De Cock, Valerie, Dauvilliers, Yves, Fantini, Maria L., Ferini-Strambi, Luigi, Gabelia, David, Iranzo, Alex, Leu-Semenescu, Smaranda, Mitterling, Thomas, Miyamoto, Masayuki, Miyamoto, Tomoyuki, Montplaisir, Jacques Y., Oertel, Wolfgang, Pelletier, Amélie, Prunetti, Paolo, Puligheddu, Monica, Santamaria, Joan, Sonka, Karel, Unger, Marcus, Wolfson, Christina, Zucconi, Marco, Terzaghi, Michele, Högl, Birgit, Mayer, Geert, Manni, Raffaele · 2014 · Neurology
Cited by 107

The DOI matches its Crossref record.

Abstract

OBJECTIVE: This controlled study investigated associations between comorbidity and medication in patients with polysomnographically confirmed idiopathic REM sleep behavior disorder (iRBD), using a large multicenter clinic-based cohort. METHODS: Data of a self-administered questionnaire on comorbidity and medication use of 318 patients with iRBD and 318 matched controls were analyzed. Comparisons between cases and controls were made using logistic regression analysis. RESULTS: Patients with iRBD were more likely to report depression (odds ratio [OR] 2.0, 95% confidence interval [CI] 1.3-2.9) and concomitant antidepressant use (OR 2.2, 95% CI 1.4-3.6). Subanalysis of antidepressant agents revealed that the increased use of antidepressants in iRBD was due to selective serotoninergic reuptake inhibitors (OR 3.6, 95% CI 1.8-7.0) and not due to other antidepressant classes. Patients with iRBD reported more lifetime antidepressant use than comorbid depression (antidepressant use: OR 1.9, 95% CI 1.1-3.3; depression: OR 1.6, 95% CI 1.0-2.5). Patients with iRBD reported more ischemic heart disease (OR 1.9, 95% CI 1.1-3.1). This association did not change substantially when adjusting for cardiovascular risk factors (OR 2.3, 95% CI 1.3-3.9). The use of inhaled glucocorticoids was higher in patients with iRBD compared to controls (OR 5.3, 95% CI 1.8-15.8), likely reflecting the higher smoking rate in iRBD (smoking: OR 15.3, 95% CI 2.0-118.8; nonsmoking: OR 2.4, 95% CI 0.4-13.2) and consequent pulmonary disease. CONCLUSIONS: This large study confirms the association between comorbid depression and antidepressant use in iRBD. In addition, there was an unexpected association of iRBD with ischemic heart disease that was not explained by cardiovascular risk factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000000247

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 107

Metadata

Authors
Frauscher, B., Jennum, P., Ju, Y.-E. S., Postuma, R. B., Arnulf, I., Cochen De Cock, V., Dauvilliers, Y., Fantini, M. L., Ferini-Strambi, L., Gabelia, D., Iranzo, A., Leu-Semenescu, S., Mitterling, T., Miyamoto, M., Miyamoto, T., Montplaisir, J. Y., Oertel, W., Pelletier, A., Prunetti, P., Puligheddu, M., Santamaria, J., Sonka, K., Unger, M., Wolfson, C., Zucconi, M., Terzaghi, M., Högl, B., Mayer, G., & Manni, R.
Venue
Neurology
Published
2014-03-25
Volume
82
Issue
12
Pages
1076-1079
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W1994270949
Cited by
107
References
0
FWCI
7.57
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comorbidity and medication in REM sleep behavior disorder: A multicenter case-control study. https://app.cochat.ai/papers/10.1212/wnl.0000000000000247
The paper
Frauscher, B., Jennum, P., Ju, Y.-E. S., Postuma, R. B., Arnulf, I., Cochen De Cock, V., Dauvilliers, Y., Fantini, M. L., Ferini-Strambi, L., Gabelia, D., Iranzo, A., Leu-Semenescu, S., Mitterling, T., Miyamoto, M., Miyamoto, T., Montplaisir, J. Y., Oertel, W., Pelletier, A., Prunetti, P., . . . Manni, R. (2014). Comorbidity and medication in REM sleep behavior disorder: A multicenter case-control study. Neurology. https://doi.org/10.1212/wnl.0000000000000247

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.